NuPathe Inc. (PATH) - Product Pipeline Analysis

NuPathe Inc. (PATH) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide33 Pages Price :
$ 750

NuPathe Inc. (NuPathe) is a pharmaceutical and healthcare company, based in the US. It develops and commercializes branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The companys CNS product candidates include NP101migraine, NP201-parkinsons disease and NP202-schizophrenia and bipolar disorder. Its current drug development candidates use two proprietary medication delivery technologies such as smartrelief and LAD. NuPathes current collaborations are University of Pennsylvania concerning Evonik Industries AG, Inc. and LTS Lohmann Therapie-Systeme AG. The company was established in the year 2005. NuPathe is headquartered in Conshohocken, Pennsylvania, the US.

This report is a source for data, analysis and actionable intelligence on the NuPathe Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
NuPathe Inc. - Major Products and Services 5
NuPathe Inc. Pipeline Products by Equipment Type 6
NuPathe Inc. Pipeline Products by Development Stage 8
NuPathe Inc. Pipeline Products by Therapy Area 10
NuPathe Inc. Pipeline Products by Trial Phase 12
NuPathe Inc. Pipeline Products by Milestone Summary 14
NP201 16
NP201 Product Status 16
NP201 Product Description 16
NP202 17
NP202 Product Status 17
NP202 Product Description 17
NP202 Product Milestone 17
NP202 Product Patent Details 18
Zelrix 19
Zelrix Product Status 19
Zelrix Product Description 19
Zelrix Product Milestone 19
Zelrix Clinical Trial 20
Zelrix Product Patent Details 21
NuPathe Inc. - Key Competitors 24
NuPathe Inc. - Key Employees 25
NuPathe Inc. - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
NuPathe Inc., Recent Developments 27
Jul 25, 2012: NuPathe Appoints Armando Anido As CEO 27
May 10, 2012: NuPathe Reports Q1 2012 Results 27
Mar 20, 2012: NuPathe Reports Q4 2011 Results 27
Nov 14, 2011: NuPathe Reports Q3 2011 Results 28
Nov 02, 2011: NuPathe Appoints Bart Dunn As Vice President, Corporate Development And Licensing 29
Aug 15, 2011: NuPathe Reports Q2 2011 Results 29
Jun 02, 2011: NuPathe To Present Additional Migraine Patch Data From Three Trials At AHS 30
May 24, 2011: NuPathe Appoints Robert Murphy As Vice President Of Sales And David McGovern As Head Of Marketing 31
May 10, 2011: NuPathe Reports Net Loss Of $3.7m For Q1 2011 31
May 02, 2011: NuPathe Announces Allowance Of US Patent Application For Migraine Patch 32

Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Table


NuPathe Inc., Key Facts 1
NuPathe Inc. Key Pipeline Products by Equipment Type 1
NuPathe Inc. Key Pipeline Products by Therapy Area 1
NuPathe Inc. Key Pipeline Products by Development Stage 1
NuPathe Inc. Key Pipeline Products by Trial Phase 1
NuPathe Inc., Key Facts 4
NuPathe Inc., Major Products and Services 5
NuPathe Inc. Number of Pipeline Products by Equipment Type 6
NuPathe Inc. Pipeline Products by Equipment Type 7
NuPathe Inc. Number of Pipeline Products by Development Stage 8
NuPathe Inc. Pipeline Products by Development Stage 9
NuPathe Inc. Number of Pipeline Products by Therapy Area 10
NuPathe Inc. Pipeline Products by Therapy Area 11
NuPathe Inc. Number of Pipeline Products by Trial Phase 12
NuPathe Inc. Pipeline Products by Trial Phase 13
NuPathe Inc. Number of Pipeline Products By Milestone Summary 14
NuPathe Inc. Pipeline Products by Milestone Summary 15
NP201 - Product Status 16
NP201 - Product Description 16
NP202 - Product Status 17
NP202 - Product Description 17
NP202 - Product Milestone 17
NP202 - Patent Details1 18
Zelrix - Product Status 19
Zelrix - Product Description 19
Zelrix - Product Milestone 19
Zelrix - A Phase I, Single Center, Open Label, Randomized, Single-Dose, Two Way Crossover Study 20
Zelrix - Patent Details1 21
Zelrix - Patent Details2 21
Zelrix - Patent Details3 22
Zelrix - Patent Details4 22
Zelrix - Patent Details5 22
Zelrix - Patent Details6 23
Zelrix - Patent Details7 23
NuPathe Inc., Key Employees 25

List of Chart


NuPathe Inc. Pipeline Products by Equipment Type 6
NuPathe Inc. Pipeline Products by Development Stage 8
NuPathe Inc. Pipeline Products by Therapy Area 10
NuPathe Inc. Pipeline Products by Trial Phase 12
NuPathe Inc. Pipeline Products by Milestone Summary 14

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top